Shamsuddin Pepermintwala
Psychiatry · Dallas, TXNPI 1316035546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $565 and has fallen 56.8% since, to $244 in 2025.
Across 128 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$443
- AbbVie$429
- Takeda Pharmaceuticals U.S.A., Inc.$413
- Alkermes, Inc.$344
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$180
- Alfasigma USA, Inc.$160
- plus $771 from 12 others
What the payments were for
- Food & beverage$2,739100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 31 | $443 |
| AbbVie(2 entities) | 16 | $429 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $413 |
| Alkermes, Inc. | 12 | $344 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $180 |
| Alfasigma USA, Inc. | 8 | $160 |
| Johnson & Johnson | 3 | $137 |
| Neurocrine Biosciences, Inc. | 2 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Lundbeck LLC | 4 | $93 |
| Ironshore Pharmaceuticals Inc. | 4 | $83 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Shire North American Group Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Neuronetics, Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
How this compares
$2,739 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.